KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $6.0 million.

  • Fulgent Genetics' Depreciation & Amortization (CF) rose 199.32% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.2 million, marking a year-over-year decrease of 421.86%. This contributed to the annual value of $24.9 million for FY2024, which is 464.75% down from last year.
  • As of Q3 2025, Fulgent Genetics' Depreciation & Amortization (CF) stood at $6.0 million, which was up 199.32% from $6.1 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Depreciation & Amortization (CF) ranged from a high of $9.8 million in Q3 2022 and a low of $1.9 million during Q1 2021
  • Its 5-year average for Depreciation & Amortization (CF) is $5.9 million, with a median of $6.2 million in 2024.
  • Per our database at Business Quant, Fulgent Genetics' Depreciation & Amortization (CF) soared by 34043.72% in 2021 and then crashed by 3463.34% in 2023.
  • Fulgent Genetics' Depreciation & Amortization (CF) (Quarter) stood at $3.5 million in 2021, then surged by 180.78% to $9.8 million in 2022, then tumbled by 33.35% to $6.5 million in 2023, then fell by 5.22% to $6.2 million in 2024, then dropped by 2.49% to $6.0 million in 2025.
  • Its last three reported values are $6.0 million in Q3 2025, $6.1 million for Q2 2025, and $5.9 million during Q1 2025.